Lappe Mark bought INBX
October 14, 2026 · Form 4 insider transaction
Lappe Mark bought 100 shares of Inhibrx Biosciences, Inc. at $85.76 per share, a transaction worth $8.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
100
Price
$85.76
Total value
$8.6K
InsiderLappe Mark
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateOctober 14, 2026
Filing dateOctober 14, 2026
Shares owned after745,588
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
These securities are directly owned by the Lappe Family Trust. Mark P. Lappe is a trustee of the Lappe Family Trust and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Lappe Family Trust.